| Literature DB >> 19374780 |
Anne T Saber1, Sabina Halappanavar, Janne K Folkmann, Jette Bornholdt, Anne Mette Z Boisen, Peter Møller, Andrew Williams, Carole Yauk, Ulla Vogel, Steffen Loft, Håkan Wallin.
Abstract
BACKGROUND: Epidemiologic and animal studies have shown that particulate air pollution is associated with increased risk of lung and cardiovascular diseases. Although the exact mechanisms by which particles induce cardiovascular diseases are not known, studies suggest involvement of systemic acute phase responses, including C-reactive protein (CRP) and serum amyloid A (SAA) in humans. In this study we test the hypothesis that diesel exhaust particles (DEP) - or carbon black (CB)-induced lung inflammation initiates an acute phase response in the liver.Entities:
Year: 2009 PMID: 19374780 PMCID: PMC2673201 DOI: 10.1186/1743-8977-6-12
Source DB: PubMed Journal: Part Fibre Toxicol ISSN: 1743-8977 Impact factor: 9.400
Hepatic mRNA expression levels of Sap, Saa1 and Saa3
| Marker | 0.9% NaCl i.p | LPS i.p. |
| 0.00164 ± 0.00057 | 0.00408 ± 0.00055* | |
| 0.00866 ± 0.00411 | 0.04081 ± 0.00423*** | |
| 0.00003 ± 0.00002 | 0.00360 ± 0.00087*** |
Relative hepatic mRNA expression levels of acute-phase markers in mice measured 6 h after i.p. injection of 12.5 mg/kg LPS or 0.9% NaCl
Messenger RNA expression levels were normalized to 18S rRNA. Mean ± SEM is shown (n = 4)
*P < 0.05 versus 0.9% NaCl
***P < 0.001 versus 0.9% NaCl
Figure 1Hepatic mRNA expression levels of . Relative Sap (white bars), Saa1 (grey bars) and Saa3 (black bars) mRNA expression levels in the liver of mice exposed to filtered air, DEP or CB by inhalation. Messenger RNA expression levels were normalized to 18S rRNA. Mean+SEM is shown. Each group consisted of 7–8 animals.
List of genes up or down regulated in the livers of mice exposed to CB or DEP by inhalation
| NM_008458 * | Serine (or cysteine) proteinase inhibitor, clade A, member 3C (Serpina3c) | -1.89 | -2.00 |
| NM_009696 * | Apolipoprotein E (Apoe) | -1.69 | -1.64 |
| NM_025360 * | Transmembrane emp24 domain containing 3 (Tmed3) | -1.29 | -1.37 |
| NM_001011744 ** | Olfactory receptor 105 (Olfr105) | 1.35 | 1.36 |
| NM_020569 ** | Parkinson disease (autosomal recessive, early onset) 7 (Park7) | -1.31 | -1.26 |
| AK045923 ** | Adult male corpora quadrigemina cDNA, RIKEN full-length enriched library | 1.23 | 1.21 |
| NM_026987 ** | DEAH (Asp-Glu-Ala-His) box polypeptide 16 (Dhx16) | 1.20 | 1.16 |
| NM_008113 ** | Rho GDP dissociation inhibitor (GDI) gamma (Arhgdig) | -1.24 | -1.18 |
| NM_011174 ** | Proline rich protein HaeIII subfamily 1 (Prh1) | -1.38 | -1.19 |
| NM_146350 ** | Olfactory receptor 1123 (Olfr1123) | -1.31 | -1.21 |
| NM_010324 ** | Glutamate oxaloacetate transaminase 1, soluble (Got1) | -1.38 | -1.24 |
| NM_032541 ** | Hepcidin antimicrobial peptide 1 (Hamp1) | -1.57 | -1.31 |
| NM_009997 ** | cytochrome P450, family 2, subfamily a, polypeptide 4 (Cyp2a4) | -1.78 | -1.47 |
| NM_027853 ** | RIKEN cDNA 0610006F02 gene (0610006F02Rik) | -1.69 | -1.32 |
| NM_022434 ** | Cytochrome P450, family 4, subfamily f, polypeptide 14 (Cyp4f14) | -1.69 | -1.25 |
| AK078353 ** | 10 days neonate cerebellum cDNA, RIKEN full-length enriched library | 1.29 | 1.11 |
| NM_008281 ** | Hepsin (Hpn) | -1.48 | -1.21 |
| NM_025363 ** | RIKEN cDNA 1110001J03 gene (1110001J03Rik) | -1.23 | -1.09 |
| NM_175641 ** | Latent transforming growth factor beta binding protein 4 (Ltbp4) | 1.19 | 1.07 |
| NM_177657 ** | Hypothetical protein D630003M21 (D630003M21) | -1.27 | -1.08 |
| NM_177661 ** | RIKEN cDNA C130079G13 gene (C130079G13Rik) | -1.32 | -1.09 |
| AK044171 ** | 10 days neonate cortex cDNA, RIKEN full-length enriched library | -1.19 | -1,.6 |
| NM_027318 ** | Zinc finger, HIT domain containing 1 (Znhit1) | -1.23 | -1.05 |
| NM_008081 ** | UDP-N-acetyl-alpha-D-galactosamine:(Galgt2) | -1.28 | -1,.5 |
| NM_026171 ** | Nuclear VCP-like (Nvl) | 1.39 | 1.01 |
| NM_007506 *** | ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c (subunit 9), isoform 1 (Atp5g1) | -1.18 | -1.24 |
| BC013546 *** | RIKEN cDNA 1810054G18 gene | -1.25 | -1.32 |
| BF531488 *** | BF531488 602091718F1 NCI_CGAP_Co24 | -1.02 | -1.23 |
* Significantly differentially expressed in both CB and DEP exposed group
** Significantly differentially expressed only in CB exposed group
*** Significantly differentially expressed only in DEP exposed group
Fold changes are over matched controls.